Skip to content

Ceftaroline fosamil

Teflaro, Zinforo (ceftaroline fosamil) is a small molecule pharmaceutical. Ceftaroline fosamil was first approved as Teflaro on 2010-10-29. It is used to treat escherichia coli infections, infectious skin diseases, klebsiella infections, pneumonia, and staphylococcal infections amongst others in the USA. It has been approved in Europe to treat community-acquired infections, infectious skin diseases, and pneumonia. Teflaro's patents are valid until 2031-02-10 (FDA).
Trade Name Zinforo
Common Name Ceftaroline fosamil
Indication community-acquired infections, escherichia coli infections, infectious skin diseases, klebsiella infections, pneumonia, staphylococcal infections, streptococcal infections
Drug Class Cephalosporins; phosphoro-derivatives
Ceftaroline fosamil
Get full access now